Cited by 40Gastrointestinal motility and disordersGut microbiota and healthInfant Health and Development

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis

Open access
Rezaie, Ali, Nikfar, Shekoufeh, Abdollahi, Mohammad·2010·Archives of Medical Science

Abstract

INTRODUCTION: Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease with an obscure pathophysiology. Current treatments for IBS have modest efficacy at best and the need for a robust therapy for IBS remains unmet. As small intestinal bacterial overgrowth has been proposed to be involved in pathogenesis of IBS, antibacterial agents might be efficacious in treatment of this condition. MATERIAL AND METHODS: PubMed, Embase, Scopus, Google Scholar, Web of Science, and Cochrane Central Register of Controlled Trials were searched for studies comparing the efficacy of antibiotics in the management of IBS and/or IBS type symptoms. Data were collected from 1966 to April 2009. Clinical response was considered as our key outcome of interest. RESULTS: Of five trials that evaluated the effect of antibiotics in IBS, two randomized placebo-controlled trials met the inclusion criteria for the meta-analysis. This meta-analysis included 234 patients with IBS-type symptoms of whom 181 met the Rome criteria for IBS. The pooled relative risk (RR) for "clinical response in IBS" was 2.04 (95% confidence interval [CI] of 1.23-3.40, p = 0.0061). The pooled RR for "clinical response in IBS-type symptoms" was 2.06 (95% CI of 1.3-3.27, p = 0.002). CONCLUSIONS: Although antibiotics have a statistically significant effect on IBS and bloating, given the evidence for the presence of publication bias, methodological variability of the trials and lack of a precise scientific explanation for the role of bacterial overgrowth in the pathophysiology of IBS, use of antibiotics on a regular basis in IBS patients is not recommended.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5114/aoms.2010.13507

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These broad-spectrum antibiotics are absorbable, causing local and systemic side effects.

    “however, these drugs are absorbable causing local and systemic side effects”
  • Other broad-spectrum antibiotics reducing bacterial overgrowth have been challenged in the treatment of IBS, including tetracycline, amoxicillin clavulanate, metronidazole and fluoroquinolones such as norfloxacin.

    “Other broad-spectrum antibiotics reducing bacterial overgrowth have been challenged in the treatment of IBS, including tetracycline, amoxicillin clavulanate, metronidazole and fluoroquinolones such as norfloxacin [287,288]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rezaie, A., Nikfar, S., & Abdollahi, M.
Affiliations
  • University of Alberta (CA)
  • Ministry of Health and Medical Education (IR)
  • Pharmaceutical Sciences Research Center (IR)
Corresponding author
Abdollahi, Mohammad
Venue
Archives of Medical Science
Published
2010
Volume
1
Issue
1
Pages
49-55
ISSN
1734-1922 (ISSN-L)
OpenAlex
W1981350408
Cited by
40
References
31
Citations by year
2025: 3 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 1 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 1 · 2012: 4
FWCI
2.97
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Archives of Medical Science (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Health Professions › Pharmacy › Infant Health and Development
Keywords
irritable bowel syndrome, antibiotics, small intestinal bacterial overgrowth, bloating, clinical response, Rome criteria, IBS pathophysiology, publication bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review